Can Copaxone cause a permanent dent where you inject?
Yes. Copaxone (glatiramer acetate) can cause lasting skin changes at injection sites, including indentations that may persist. The medication is known for injection-site reactions such as lumps, swelling, redness, and in some cases “lipoatrophy” (localized loss of fat under the skin), which can look like a dent or divot.
Lipoatrophy tends to be linked to repeated injections in the same area or incorrect injection technique. In some people it improves after stopping Copaxone, but it can also leave longer-lasting or permanent-looking changes.
What does a “permanent dent” usually mean with Copaxone?
Clinically, a persistent “dent” after injections is often consistent with lipoatrophy. This is a loss of subcutaneous fat at the injection site that can create a visible indentation.
These changes are different from temporary redness or swelling, which usually resolve after the reaction settles.
How can patients lower the risk of lasting injection-site dents?
Practical steps can reduce the chance of lipoatrophy-like changes:
- Rotate injection sites (do not reuse the same spot).
- Follow the injection-site guidance your prescriber or pharmacist provides (for example, using the recommended areas such as the abdomen, thighs, or upper buttocks, depending on your product instructions).
- Use the correct technique and needle handling, as instructed with Copaxone.
If you notice early lumps or skin dimpling, it’s a sign to stop using that exact spot and discuss the pattern with your clinician.
When should you contact a clinician about an injection-site dent?
Get medical advice promptly if the area:
- Is getting larger or changing shape over time
- Becomes very painful, warm, swollen, or develops drainage (to rule out infection)
- Looks like a growing skin defect or causes functional problems
Clinicians may document the site change and help you adjust technique or consider alternatives if reactions are significant.
Is it likely to go away, or is it usually permanent?
It varies. Some injection-site fat loss improves, but others can persist for months and may remain noticeable. The risk increases with repeated injections into the same small area, so early site rotation matters.
Would switching therapies help if the dent is lasting?
Sometimes. If injection-site reactions are troublesome or persistent, clinicians may suggest strategies such as stricter site rotation or switching to a different multiple-sclerosis disease-modifying therapy. Whether that’s appropriate depends on your medical history and the severity of the skin changes.
Sources: none provided in the information available to me here. If you share any Copaxone prescribing information excerpts or links you’re using, I can help interpret them precisely.